Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 May 15;4:ojac047. doi: 10.1093/asjof/ojac047

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 The Aesthetic Society.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 3. — Representative photographs of subjects at baseline and 30 days after VYC-17.5L treatment. A 29-year-old female was injected with 1 mL of VYC-17.5L at (A) day 1 and another 1 mL during optional touch-up treatment at (B) day 14 (total of 2 mL). The subject showed a 2-point improvement on the Lip Fullness Scale (LFS2). A 24-year-old female was injected with 1 mL of VYC-17.5L at (C) day 1 and another 1.3 mL at (D) day 14 (total of 2.3 mL). The subject showed a 1-point improvement on the LFS2. A 50-year-old female was injected with 2.3 mL of VYC-17.5L at (E) day 1 and did not receive touch-up treatment. (F) The subject showed a 1-point improvement on the LFS2.